PROGRAM

Abstract Information

Abstracts can only be submitted using the on-line submission form.

Hardcopy or e-mailed submission will not be accepted.

Oral presentations cannot be guaranteed.

Presentation format will be decided by the ASA committee.

Plenary Speakers include:

Dr Fred Tenover
Centers for Disease Control and Prevention (CDC)
Atlanta USA

Professor Werner Zimmerli
University Clinic of Internal Medicine, Basel University Medical Clinic
Liestal, Switzerland

Associate Professor Paul Johnson
Austin Health
Melbourne, Australia

ASA Travel Awards

ASA have made funds available for travel awards for delegates to attend Antimicrobials 2006. Awards will be made to ASA financial members presenting a proffered paper (oral or poster) at the meeting.

The awards consist of a return economy airfare, accommodation and registration.

Applicants should forward a copy of their abstract to the Secretary, Wendy Munckhof, before Friday 16 December 2005, which will then be judged by the ASA Executive.

The bioMérieux ASA Identifying Resistance Travel Award

This is awarded to an individual on the basis of a proffered paper (oral or poster) presented during the ASA's Annual Scientific Meeting dealing with the identification of bacterial resistance to antimicrobials in a routine clinical setting.

The applicant must be a financial member of the ASA. The award committee will take into account the quality and originality of the paper.

The award consists of A$1000 cash prize, a commemorative plaque, and the provisions of flights, accommodation and registration for the recipient to attend Antimicrobials 2007.

The award committee will consist of two ASA committee members and a bioMérieux staff member.

Program for Thursday, 23 February 2006

0900 - 1000: Plenary 1

Laboratory Response to Emerging Antimicrobial Resistance. How are we Doing?
Fred Tenover, CDC, United States of America

1000 - 1030: Morning Tea

1030 - 1200: Symposium 1 - All Things Antifungal

Antifungal Susceptibility Testing
David Ellis, Women's and Children's Hospital, South Australia

Controversial Antifungal Combinations
Tania Sorrell, Westmead Hospital, New South Wales

Antifungal Therapy Costs in Perspective
Sue Kirsa, Peter MacCallum Cancer Centre, Victoria

1200 - 1400: Lunch and Posters
Authors in Attendance

1400 - 1530: Proffered Papers 1
Six presentations

1530 - 1600: Afternoon Tea

1600 - 1730: Symposium 2 - Preserving Antimicrobials

Preserving Anti-Staphylococcal Antimicrobials
Ben Howden, Austin Heath, Victoria

Strategies for Decolonisation
Ronan Murray, Royal Perth Hospital, Western Australia

Meningococcal Vaccine
Diana Lennon, University of Auckland, New Zealand

1730 - 1830: Annual General Meeting

1830 - 2000: Welcome Reception

Program for Friday, 24 February 2006

0900 - 1000: Plenary 2

Treatment of Prosthetic Infections
Werner Zimmerli, Basel Iniversity, Switzerland

1000 - 1030: Morning Tea

1030 - 1230: Symposium 3 - Community MRSA

Epidemiology of Community MRSA in Australia
Geoff Coombs, Royal Perth Hospital, Western Australia

Epidemiology of Community MRSA in the United States of America
Fred Tenover, CDC, United States of America

Virulence Determinants of Community MRSA
Graeme Nimmo, Queensland Health Pathology and Scientific Services, Queensland

Antimicrobial Therapy of Community MRSA
Keryn Christiansen, Royal Perth Hospital, Western Australia

1230 - 1400: Lunch and Posters

1400 - 1530: Proffered Papers 2
Six presentations

1530 - 1600: Afternoon Tea

1600 - 1730: Symposium 4 - Severe Sepsis

Pathogenesis and Non Antimicrobial Management
Jeff Lipman, Royal Brisbane Hospital, Queensland

S aureus Sepsis
Werner Zimmerli, Basel University, Switzerland

Antimicrobials in ICU - The Long and the Short of it
David Looke, Princess Alexandra Hospital, Queensland

Program for Saturday, 25 February 2006

0900 - 1000: Plenary 3

Mycobacteria ulcerans. Out of Africa
Paul Johnson, Austin Health, Victoria

1000- 1030: Morning Tea

1030 - 1200: Symposium 5 - Multidrug Resistant Gram Negative Bacteria

Impact of Carbapenemases
Jon Iredell, Westmead Hospital, New South Wales

Colistin: What is the Correct Dose?
Roger Nation, Victorian College of Pharmacy, Victoria

Infection Control Aspects of Multidrug Resistant Gram Negative Bacteria
Denis Spelman, The Alfred Hospital, Victoria

1200 - 1300: Lunch and Posters

1300 - 1600: Workshop 1 - How Good is your Laboratory's Antimicrobial Susceptibility Method?

Overview
John Turnidge, Women's and Children's Hospital, South Australia

Methods
Vitek 2
Narelle George, Queensland Health Pathology and Scientific Services, Queensland

CLSI Disc Difffusion
Fred Tenover, CDC, United States of America

CDS Disc Diffusion
Sydney Bell, Prince of Wales Hospital, New South Wales

BSAC Disc Diffusion
Clare Franklin, Alfred Hospital, Victoria

1300 - 1600: Workshop 2 - Infectious Diseases Pharmacists' Special Interest Group workshop

Management of tuberculosis
Dr Tom Gottlieb, Senior Specialist in Infectious Diseases & Microbiology, Concord Hospital, Sydney

Update on Therapeutic Guidelines: Antibiotic
Jenny Johnstone, Editor, Therapeutic Guidelines

Antimicrobials on the horizon
Matthew Rawlins, Infectious Diseases Pharmacist, Royal Perth Hospital

The CAPTION project: a final report
Dr Kylie McIntosh, Project Officer, Victorian Drug Usage Evaluation Group

Committee Of Specialty Practice (COSP) meeting
Sharmila Melvani, Infectious Diseases Pharmacist, Austin Health, Melbourne

1600 - 1700: Closing Reception

Social Program

Welcome Reception
Thursday, 23 February 2006

Time: 18:30 - 20:00
Venue: Terrace View Room ad Pool Terrace, Crowne Plaza Coogee Beach
Cost: Included in the full delegate registration fee. Additional tickets may be purchased at a cost of $55 (inclusive of GST).

Conference Dinner
Friday, 24 February 2006

Time: 19:00 - 23:00
Venue: Oceanic Ballroom
Cost: $75 (inclusive of GST) for registered delegate. Additional tickets (all inclusive) may be purchased at a cost of $90 (inclusive of GST)

Closing Cocktails
Saturday, 25 February 2006

Time: 16:00 - 16:45
Venue: Pier Bar Crowne Plaza Coogee Beach
Cost: Included in the full delegate registration fee.

Dr Fred Tenover

Dr Fred Tenover is the Associate Director for Laboratory Science at the Centers for Disease Control and Prevention (CDC) in Atlanta, USA. He is on the Editorial Board for Antimicrobial Agents and Chemotherapy and Microbial Drug Resistance and is a Member of the ISO Committee on Global Standardization of Antimicrobial Susceptibility Testing, and the NCCLS Subcommittees on Antimicrobial Susceptibility Testing and Antimicrobial Susceptibility Testing Working Group on Fastidious Pathogens.

Fed has produced over 240 peer reviews publications, written 33 book chapters and submitted over 100 abstracts at national and international meetings. In addition he has been invited to present at over 125 conferences.

Currently his major areas of research include:

Characterisation of novel antimicrobial resistance genes in bacterial pathogens.

Development of novel methods of detection of antimicrobial resistance in bacteria in clinical laboratories

Use of pulsed-field gel electrophoresis, nucleic amplification techniques, and DNA sequencing for bacterial strain typing

Use of molecular techniques for epidemiological studies of bacterial infections

During "Antimicrobials 2006" Fred will be presenting the plenary "The Laboratory Response to Emerging Antimicrobial Resistance: How are we Doing?" In addition Fred will be participating in the symposium "Community MRSA and the antimicrobial susceptibility testing workshop "How Good is your Laboratory's Antimicrobial Susceptibility Method?"

Professor Werner Zimmerli

Professor Werner Zimmerli is the Head of the University Clinic of Internal Medicine at the Basel University Medical Clinic, Liestal in Switzerland. In 1999 he was made a full Professor of medicine at the Medical Faculty at the University of Basel. He is a member of the Swiss Society of Internal Medicine and since 2000 a member of the scientific board on the Infectious Diseases program at German Universities. During his career Werner has been granted many awards including the 2004 Aventis Award for PCR of M. tuberculosis, the 2003 MSD Award for experimental meningitis and the SKB Award for the controlled study in patients with orthopaedic device-related infections.

His current scientific activity includes experimental work and clinical studies in the field of device-related infections, granulocyte function, sepsis, pharmacodynamics (skin blister studies), physiology and pathology of sCD14.

He has written many peer reviewed articles including a review on "Prosthetic-Joint Infections" in 2004.

During "Antimicrobials 2006" Werner will be presenting the plenary "Treatment f of Prosthetic Infections". In addition Werner will be participating in the symposium "Severe Sepsis".

Associate Professor Paul Johnson

The Australian plenary speaker for Antimicrobials 2006 is Associate Professor Paul Johnson.

Paul is an infectious diseases physician trained at Austin Hospital, Fairfield Infectious Diseases Hospital and the Royal Children's Hospital, Melbourne. In 2002 he worked with Professor Stewart Cole at the Pasteur Institute in Paris. He is currently Deputy Director, Infectious Diseases Department, Austin Health in Melbourne.

He has a background in microbiological and epidemiological research and completed a PhD (Melbourne University, 1997) on pathogenesis and human immune response to Haemophilus influenzae type B infections at the Royal Children's Hospital. In 1993-95 he investigated an outbreak of Mycobacterium ulcerans infection on Phillip Island in conjunction with the Victorian Department of Human Services. In 1995 he designed and ran a large prevalence survey of tuberculosis infection in Melbourne secondary schools. The research team he created developed a new rapid diagnostic test for M. ulcerans infection, and was the first in the world to identify M. ulcerans in environmental samples. This work led to Paul being awarded the Glaxo Welcome Agents for Change prize for clinician-research. In 1998 he was invited by WHO to join their Global Buruli Ulcer Taskforce of which he remains an active member

During "Antimicrobials 2006" Paul will be presenting the plenary "Mycobacteria ulcerans: Out of Africa"